The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
CD44 cell adhesion molecules.
Open accessAbstract
The CD44 proteins form a ubiquitously expressed family of cell surface adhesion molecules involved in cell-cell and cell-matrix interactions. The multiple protein isoforms are encoded by a single gene by alternative splicing and are further modified by a range of post-translational modifications. CD44 proteins are single chain molecules comprising an N-terminal extracellular domain, a membrane proximal region, a transmembrane domain, and a cytoplasmic tail. The CD44 gene has only been detected in higher organisms and the amino acid sequence of most of the molecule is highly conserved between mammalian species. The principal ligand of CD44 is hyaluronic acid, an integral component of the extracellular matrix. Other CD44 ligands include osteopontin, serglycin, collagens, fibronectin, and laminin. The major physiological role of CD44 is to maintain organ and tissue structure via cell-cell and cell-matrix adhesion, but certain variant isoforms can also mediate lymphocyte activation and homing, and the presentation of chemical factors and hormones. Increased interest has been directed at the characterisation of this molecule since it was observed that expression of multiple CD44 isoforms is greatly upregulated in neoplasia. CD44, particularly its variants, may be useful as a diagnostic or prognostic marker of malignancy and, in at least some human cancers, it may be a potential target for cancer therapy. This review describes the structure of the CD44 gene and discusses some of its roles in physiological and pathological processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
CD44 and Its Interaction with Extracellular Matrix
Lesley, J., Hyman, R., & Kincade, P. W. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60537-4 · Cited by 1,059
Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., & Bell, J. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12160 · Cited by 1,015
Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)
Weber, G. F., Ashkar, S., Glimcher, M. J., & Cantor, H. (1996) · Science · doi:10.1126/science.271.5248.509 · Cited by 949
McKee, C. M., Penno, M. B., Cowman, M., Burdick, M. D., Strieter, R. M., Bao, C., & Noble, P. W. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119054 · Cited by 806
Tsukita, S., Oishi, K., Sato, N., Sagara, J., Kawai, A., & Tsukita, S. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.2.391 · Cited by 779
Stamenkovic, I., Amiot, M., Pesando, J. M., & Seed, B. (1989) · Cell · doi:10.1016/0092-8674(89)90638-7 · Cited by 672
Yonemura, S., Hirao, M., Doi, Y., Takahashi, N., Kondo, T., Tsukita, S., & Tsukita, S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.885 · Cited by 613
Stamenkovic, I., Aruffo, A. A., Amiot, M., & Seed, B. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07955.x · Cited by 573
Requirement for CD44 in Activated T Cell Extravasation into an Inflammatory Site
DeGrendele, H. C., Estess, P., & Siegelman, M. H. (1997) · Science · doi:10.1126/science.278.5338.672 · Cited by 563
Cited by
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Cell Encapsulation in Biodegradable Hydrogels for Tissue Engineering Applications
Nicodemus, G. D., & Bryant, S. J. (2008) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2007.0332 · Cited by 1,239
Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis
Pittayapruek, P., Meephansan, J., Prapapan, O., Komine, M., & Ohtsuki, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060868 · Cited by 1,099
Huang, E. H., Hynes, M. J., Zhang, T., Ginestier, C., Dontu, G., Appelman, H., Fields, J. Z., Wicha, M. S., & Boman, B. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4418 · Cited by 1,045
Senbanjo, L. T., & Chellaiah, M. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00018 · Cited by 842
Bourboulia, D., & Stetler-Stevenson, W. G. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.05.002 · Cited by 710
Balic, M., Lin, H., Young, L., Hawes, D., Giuliano, A., McNamara, G., Datar, R. H., & Cote, R. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0169 · Cited by 681
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
Izumi, H., Torigoe, T., Ishiguchi, H., Uramoto, H., Yoshida, Y., Tanabe, M., Ise, T., Murakami, T., Yoshida, T., Nomoto, M., et al. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00106-3 · Cited by 613
Hyaluronan-binding Proteins: Tying Up the Giant
Day, A. J., & Prestwich, G. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100036200 · Cited by 567
CD44: A Multifunctional Mediator of Cancer Progression
Hassn Mesrati, M., Syafruddin, S. E., Mohtar, M. A., & Syahir, A. (2021) · Biomolecules · doi:10.3390/biom11121850 · Cited by 492
The human SWI/SNF subunit Brm is a regulator of alternative splicing
Batsché, E., Yaniv, M., & Muchardt, C. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1030 · Cited by 471
Laino, G., D'Aquino, R., Graziano, A., Lanza, V., Carinci, F., Naro, F., Pirozzi, G., & Papaccio, G. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050325 · Cited by 460
Diels−Alder Click Cross-Linked Hyaluronic Acid Hydrogels for Tissue Engineering
Nimmo, C. M., Owen, S. C., & Shoichet, M. S. (2011) · Biomacromolecules · doi:10.1021/bm101446k · Cited by 436
A Comparative Review of Melanocytic Neoplasms
Smith, S. H., Goldschmidt, M. H., & McManus, P. M. (2002) · Veterinary Pathology · doi:10.1354/vp.39-6-651 · Cited by 431
Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin
Brown, M., & Jones, S. (2005) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2004.01180.x · Cited by 373
The role of Osteopontin in tumor metastasis
Wai, P. Y., & Kuo, P. C. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.03.028 · Cited by 365
Gardina, P. J., Clark, T. A., Shimada, B., Staples, M. K., Yang, Q., Veitch, J., Schweitzer, A., Awad, T., Sugnet, C., Dee, S., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-325 · Cited by 352
Hyaluronan: Pharmaceutical Characterization and Drug Delivery
Liao, Y.-H., Jones, S. A., Forbes, B., Martin, G. P., & Brown, M. B. (2005) · Drug Delivery · doi:10.1080/10717540590952555 · Cited by 342
β-Catenin—A Linchpin in Colorectal Carcinogenesis?
Wong, N. A. C. S., & Pignatelli, M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64856-0 · Cited by 341
Osteopontin: regulation in tumor metastasis
Wai, P. Y., & Kuo, P. C. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9104-9 · Cited by 321
The prognostic molecular markers in hepatocellular carcinoma
Qin, L.-X. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i3.385 · Cited by 311
Moloney, E. B., de Winter, F., & Verhaagen, J. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00252 · Cited by 307
Hyaluronic acid and its derivatives in drug delivery and imaging: Recent advances and challenges
Tripodo, G., Trapani, A., Torre, M. L., Giammona, G., Trapani, G., & Mandracchia, D. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.032 · Cited by 286
Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy
Zhi, D., Yang, T., Yang, J., Fu, S., & Zhang, S. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.027 · Cited by 283
Gonzalez-Begne, M., Lu, B., Han, X., Hagen, F. K., Hand, A. R., Melvin, J. E., & Yates (2009) · Journal of Proteome Research · doi:10.1021/pr800658c · Cited by 281
Tissue-resident memory T cells at the center of immunity to solid tumors
Amsen, D., van Gisbergen, K. P. J. M., Hombrink, P., & van Lier, R. A. W. (2018) · Nature Immunology · doi:10.1038/s41590-018-0114-2 · Cited by 278
Choi, K. Y., Saravanakumar, G., Park, J. H., & Park, K. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.10.029 · Cited by 264
Therapies targeting cancer stem cells: Current trends and future challenges
Dragu, D. L. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i9.1185 · Cited by 257
Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells
Masters, K. S., Shah, D. N., Leinwand, L. A., & Anseth, K. S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.018 · Cited by 256
Möckl, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00253 · Cited by 253
CD44 and β3 Integrin Organize Two Functionally Distinct Actin-based Domains in Osteoclasts
Chabadel, A., Bañon-Rodríguez, I., Cluet, D., Rudkin, B. B., Wehrle-Haller, B., Genot, E., Jurdic, P., Anton, I. M., & Saltel, F. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-04-0378 · Cited by 154
Polysaccharide matrices used in 3D in vitro cell culture systems
Diekjürgen, D., & Grainger, D. W. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.06.020 · Cited by 125
Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
Deng, J., Wang, L., Chen, H., Hao, J., Ni, J., Chang, L., Duan, W., Graham, P., & Li, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9908 · Cited by 115
El Gaamouch, F., Audrain, M., Lin, W.-J., Beckmann, N., Jiang, C., Hariharan, S., Heeger, P. S., Schadt, E. E., Gandy, S., Ehrlich, M. E., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-0357-x · Cited by 92
Human cancer stem cells are a target for cancer prevention using (−)-epigallocatechin gallate
Fujiki, H., Sueoka, E., Rawangkan, A., & Suganuma, M. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2515-2 · Cited by 64
Chellaiah, M. A., & Ma, T. (2013) · BioMed Research International · doi:10.1155/2013/302392 · Cited by 37
Ramezani, S., Parkhideh, A., Bhattacharya, P. K., Farach-Carson, M. C., & Harrington, D. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.657701 · Cited by 11
Metadata
- Authors
- Goodison, S., Urquidi, V, & Tarin, D.
- Venue
- Molecular Pathology
- Publisher
- BMJ
- Published
- 1999-08
- Volume
- 52
- Issue
- 4
- Pages
- 189-196
- ISSN
- 1366-8714 (ISSN-L)
- 1472-4154
- OpenAlex
- W2037100155
- Cited by
- 679
- References
- 77
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.